- | Country : -
- | organs : -
- | Specialty : -
Extract
The objective of this study is to evaluate the effect of cabozantinib compared to prednisone on overall survival in men with previously treated metastatic castration-resistant prostate cancer with bone-dominant disease who have experienced disease progression on docetaxel-containing chemotherapy and abiraterone or MDV3100.
Inclusion criteria
- Metastatic Castration-resistant Prostate Cancer (CRPC)